Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15282641Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$2.5M
Full award amounts, FY2025
Award Records
2
Records listing this PI
Award-Linked Rank
#4,563
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Thomas Blue as a PI. Multi-PI records show the full award amount for context.
- 1UM1DA064499-01UM1A patient preference trial of sublingual versus extended-release buprenorphine telemedicine and pharmacy linkage for individuals re-entering the community from jail$1.4Maward amount
- 5R01DA058674-03R01A comparative effectiveness trial of sublingual versus extended-release buprenorphine with individuals leaving a carceral setting$1.1Maward amount
Award organization
Organizations that administered FY2025 awards listing Thomas Blue as a PI.
FY2025 award administered by Friends Research Institute, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardFriends Research Institute, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #4563
- 2025Entered Top 25% NationallyRanked #4563
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Thomas Blue.